Consult
Log In
Menu
Consult
Log in

Josh Forsythe

Recent Posts by Josh Forsythe:

by Josh Forsythe, on June 11, 2018

PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that the Department of Anatomical Pathology PathWest Laboratory Medicine will use the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for clinical genomic analytics, classification, interpretation and reporting.

Read Story
Topics:News

by Josh Forsythe, on June 1, 2018

Topics:News

by Josh Forsythe, on May 23, 2018

MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical genomics solutions, announced today that it has appointed Michael L. Sanderson as Chief Executive Officer and Director of the Board. In his new role, Sanderson will execute on the company’s strategy to integrate PierianDx’s unique value proposition for molecular labs into the broader precision medicine and healthcare delivery markets.

Read Story
Topics:News

by Josh Forsythe, on May 13, 2018

MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that it has executed a distribution agreement with ScienceVision, a leading provider of end-to-end genomic solutions in the Asia Pacific region.

Read Story
Topics:News

by Josh Forsythe, on April 17, 2018

PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to advance precision medicine.  The partnership includes investment and collaboration on product, service and market expansion.

Read Story
Topics:News

by Josh Forsythe, on April 13, 2018

One of America’s greatest inventors, Thomas Edison, didn’t invent the light bulb. The technology already existed, and he merely accelerated its adoption by optimizing it and later developing a system to deliver it.  He knew that going from the spark of one light bulb filament to powering homes and factories would require not only the right technology but the right approach.  

Read Story
Topics:News

by Josh Forsythe, on April 12, 2018

PierianDx, the leading genomics technology company that enables precision medicine, announced today at the annual meeting of the American College of Medical Genetics and Genomics (ACMG)  a series of enhanced germline testing features for the company’s enterprise informatics software platform.

Read Story
Topics:News

by Josh Forsythe, on April 11, 2018

PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics software platform, the Clinical Genomics WorkSpace (CGW). Chris will report to PierianDx CEO Rakesh Nagarjan, M.D., Ph.D., and oversee customer success, sales, marketing, and business development.

Read Story
Topics:News

by Josh Forsythe, on April 10, 2018

Cardiovascular disease causes more deaths worldwide than any other disease. In 2015 alone, nearly 18 million people died from cardiovascular disease. And according to the World Health Organization, most cardiovascular disease can be prevented or successfully treated by eliminating risk factors such as smoking and tobacco use, obesity, and physical inactivity. [1]

Read Story
Topics:News

by Josh Forsythe, on April 6, 2018

PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that TriCore Reference Laboratories will utilize the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for genomic analytics, classification, interpretation and reporting. TriCore will join more than 50 other customers who benefit from shared interpretations in the PierianDx KnowledgeSpace, a knowledgebase comprised of millions of biomedical findings that are continually updated.

Read Story
Topics:News

by Josh Forsythe, on April 6, 2018

Flashback: the Human Genome Project was launched in 1990 by Nobel Laureate, Dr. James Watson, at the NIH (National Institutes of Health). All told, sequencing the first human genome took 13 years and cost between $500 million and  $1 billion. Although exciting, the initiative attracted its share of critics who described the initiative as “nearly impossible,” and “un-thought-out science,” because it was behind schedule and over budget from the start, not to mention that it would generate a vast amount of “uninterpretable and useless data.” [1]

Read Story
Topics:News

by Josh Forsythe, on April 5, 2018

In case you missed it, PierianDx customer, Inova, is launching a joint study with the National Institutes of Health (NIH) to “re-engineer” genomics. The study, called the Genomic Ascertainment Cohort (TGAC), launched in early March, will collect the genomes of 10,00 people, and then use analytics to predict phenotypic outcomes using genes and gene variants identified in the genomes. [1]

Read Story
Topics:News